Phone: (919) 843-3091
Dr. Kampov-Polevoi is a graduate of the 1st Moscow Medical School in USSR (specialty – internal medicine), who received his PhD in Pharmacology (1979) in the Institute of Pharmacology, USSR Academy of Medical Sciences (Moscow). Since 1987 he studied 12-step treatment program in USA in Rutgers State University, New Brunswick, NJ (1987), completed 6-month residency training program in Hazelden Foundation, Center City, MN (1990) and Professional-in-Residence Program at Betty Ford Chemical Dependency Treatment Center, Palm Beach, CA (1990). In 1987 – 1989, Dr. Kampov-Polevoi was the first physician who introduced 12-step substance abuse treatment model to Soviet medical community and organized first groups of Alcoholic Anonymous in Moscow (Russia) and Kishinev (Moldova). He translated and wrote original manuals on this subject. In 1991 Dr. Kampov-Polevoi permanently moved to the USA and received both clinical research training in the Chemical Dependency Treatment Program, Department of Psychiatry, University of Minnesota, Minneapolis (1991-1993) and post doctoral training in behavioral pharmacology in Skipper Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill (1993-1994). Later he completed NIMH-sponsored Clinical Psychobiology/Pharmacology Research Training Program in the Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill (1994-1997).
Dr. Kampov-Polevoi’s research career spans a wide spectrum from basic animal studies to clinical research. Although his primary research interest is the study of mechanisms of predisposition to alcohol-use disorders and individual pharmacotherapy of these disorders, he developed an interest in eating disorders after discovering the existence of high association between genetic risk of alcoholism and various characteristics of perception/consumption of sweet-tasting foods in both animals and humans.
Representative Publications: Click here for a full list of publications from PubMed
1. Garbutt JC, Osborne M, Gallop R, Barkenbus J, Grace K, Cody M, Flannery B, Kampov-Polevoy AB. Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence. Alcohol Alcohol. 2009: 44(3):293-300.
2. Kampov-Polevoy AB, Alterman A, Khalitov E, Garbutt JC. Sweet preference predicts mood altering effect of and impaired control over eating sweet foods. Eat Behav. 2006: 7(3):181-187.
3. Kampov-Polevoy AB, Eick C, Boland G, Khalitov E, Crews FT. Sweet liking, novelty seeking, and gender predict alcoholic status. Alcohol Clin Exp Res. 2004: 28(9):1291-1298.
4. Kampov-Polevoy AB, Ziedonis D, Steinberg ML, Pinsky I, Krejci J, Eick C, Boland G, Khalitov E, Crews FT. Association between sweet preference and paternal history of alcoholism in psychiatric and substance abuse patients. Alcohol Clin Exp Res. 2003: 27(12):1929-1936.
5. Kampov-Polevoy AB, Garbutt JC, Khalitov E. Family history of alcoholism and response to sweets. Alcohol Clin Exp Res. 2003: 27(11):1743-1749.